(Q44111464)

29 November 2017

title

Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans (English)

1 reference

29 November 2017

7

1 reference

29 November 2017

Gilberto Gerra

1

1 reference

29 November 2017

Amir Zaimovic

2

1 reference

29 November 2017

Gabriele Moi

3

1 reference

29 November 2017

Francesca Giusti

4

1 reference

29 November 2017

Simona Gardini

5

1 reference

29 November 2017

Roberto Delsignore

6

1 reference

29 November 2017

Teodora Macchia

8

1 reference

29 November 2017

Francesca Brambilla

9

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Behavioural Brain Research

29 November 2017

published in

1 reference

29 November 2017

volume

134

1 reference

29 November 2017

issue

1-2

1 reference

29 November 2017

page(s)

403-410

1 reference

Dopaminergic regulation of prolactin secretion in the hyperprolactinemic syndrome.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Further neuroendocrine evidence for reduced D2 dopamine receptor function in alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Personality disorder in obsessive-compulsive volunteers, well comparison subjects, and their first-degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approach

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

An inventory for assessing different kinds of hostility.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

A systematic method for clinical description and classification of personality variants. A proposal

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Neurogenetic adaptive mechanisms in alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Evidence for Reduced Dopamine D2 Receptor Sensitivity in Postwithdrawal Alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Homovanillic acid and dopamine-beta-hydroxylase in male youth: relationships with paternal substance abuse and antisocial behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Neuroendocrine correlates of temperamental traits in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Bromocriptine: Effect on Serum Prolactin and Growth Hormone in Psychogeriatric Hospital Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

MDMA elicits behavioral and neurochemical sensitization in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Neuroendocrine responses to levodopa in multiple system atrophy (MSA)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

MDMA induced dopamine release in vivo: role of endogenous serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Abnormal structure of human striatal dopamine re-uptake sites in habitually violent alcoholic offenders: a fractal analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Striatal dopamine transporter density in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucleus accumbens neuronal responses to dopamine and serotonin.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Reduced dopaminergic function in alcoholics is related to severe dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Antisociality, substance dependence, and the DRD5 gene: a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

Alcohol dependence, family history, and D2 dopamine receptor function as neuroendocrinologically assessed with apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900052-9

7 January 2021

10.1016/S0166-4328(02)00052-9

Identifiers

DOI

1 reference

29 November 2017

1 reference